Related Experiment Videos
An international perspective on anticholinergic therapy
1Asthma Centre, Toronto Hospital, Ontario, Canada.
The American Journal of Medicine
|January 29, 1996
Summary
Inhaled anticholinergic bronchodilators are key for managing chronic obstructive pulmonary disease (COPD). Combination therapy with adrenergic agents shows enhanced effectiveness in acute asthma treatment for both children and adults.
Area of Science:
- Respiratory Medicine
- Pharmacology
Background:
- Inhaled quaternary anticholinergic bronchodilators are widely used.
- They are the primary choice for managing chronic obstructive pulmonary disease (COPD).
Purpose of the Study:
- To explore the clinical utility of inhaled anticholinergic bronchodilators.
- To evaluate their role in asthma management, particularly in acute exacerbations.
Main Methods:
- Review of clinical usefulness in various settings.
- Analysis of combination therapy efficacy compared to single agents.
Main Results:
- Anticholinergic bronchodilators are the first-line treatment for COPD.
- Combination therapy with adrenergic bronchodilators is more effective in acute asthma than monotherapy.
- This finding is consistent across adult and pediatric populations.
Conclusions:
- Inhaled anticholinergic bronchodilators are essential for COPD management.
- Combination nebulizer therapy for acute asthma is effective and potentially cost-effective.
- Further research is needed to confirm cost-effectiveness.